SequelSEC

Rezolute, Inc. RZLT

Pharmaceutical Preparations · CIK 0001509261 · Fiscal year ends 0630

AnnualQuarterlyTTM
Revenue
Unavailable
Fiscal year ended 2026-03-31
Operating income
-$17.37M
Fiscal year ended 2026-03-31
Free cash flow
Unavailable
Fiscal year ended 2026-03-31

Rezolute, Inc. (RZLT) reported net income of -$16.17M for the fiscal year ended 2026-03-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Rezolute, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

Rezolute, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-31
RevenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income-$17.37M-$24.22M-$19.82MUnavailable-$20.02M-$17.08M-$16.94MUnavailable-$16.21M-$15.19M
Net income-$16.17M-$22.77M-$18.15MUnavailable-$18.91M-$15.73M-$15.38MUnavailable-$17.05M-$13.91M
Research & development$11.41M$14.35M$13.15MUnavailable$15.28M$12.63M$12.75MUnavailable$12.40M$12.04M
Weighted-average diluted sharesshares 104.04Mshares 103.69Mshares 103.42MUnavailableshares 70.03Mshares 69.94Mshares 69.74MUnavailableshares 50.81Mshares 51.41M
Pretax incomeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Income tax expenseUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Diluted EPS$-0.16$-0.22$-0.18Unavailable$-0.27$-0.22$-0.22Unavailable$-0.34$-0.27
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$5.95M$9.87M$6.67MUnavailable$4.74M$4.45M$4.19MUnavailable$3.81M$3.16M
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Rezolute, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-31
Cash & equivalents$11.24M$11.94M$9.10MUnavailable$14.60M$8.93M$10.47MUnavailable$5.93M$12.50M
Total assets$125.46M$138.63M$158.66MUnavailable$94.74M$112.01M$123.41MUnavailable$87.74M$102.15M
Current assets$122.05M$135.11M$154.71MUnavailable$88.74M$98.69M$110.18MUnavailable$82.21M$96.08M
Total liabilities$8.62M$10.63M$11.50MUnavailable$12.17M$12.42M$9.97MUnavailable$16.88M$10.42M
Current liabilities$7.70M$9.53M$10.21MUnavailable$10.53M$10.61M$7.99MUnavailable$6.96M$8.01M
Total equity incl. NCI$116.83M$128.00M$147.17MUnavailable$82.57M$99.59M$113.44MUnavailable$70.86M$91.73M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$3.20M$3.78M$3.26MUnavailable$6.50M$3.15M$2.18MUnavailable$3.50M$3.59M

Cash flow

Rezolute, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-31
Operating cash flow-$13.74M-$20.32M-$17.43MUnavailable-$17.40M-$13.67M-$16.01MUnavailable-$15.24M-$13.02M
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flow$12.28M$22.81M-$68.49MUnavailable$23.05M$11.47M-$49.41MUnavailable$8.67M$17.76M
Financing cash flow$747.00K$356.00K$911.00KUnavailable$10.00K$657.00K$5.50MUnavailable-$3.00KUnavailable
Net change in cash-$708.00K$2.85M-$85.01MUnavailable$5.66M-$1.54M-$59.92MUnavailable-$6.57M$4.45M
Stock-based compensation$4.42M$3.41M$2.53MUnavailable$1.90M$1.44M$1.40MUnavailable$1.90M$1.84M
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$8.00K$7.00K$8.00KUnavailable$7.00K$8.00K$8.00KUnavailable$9.00K$10.00K

Derived

Rezolute, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-31
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratio15.84x14.18x15.15xUnavailable8.43x9.30x13.79xUnavailable11.82x12.00x
Revenue YoY growthUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Net marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open RZLT in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-05-12View SEC filing
10-Q · Filed 2026-02-12View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-K · Filed 2025-09-17View SEC filing
10-Q · Filed 2025-05-13View SEC filing
10-Q · Filed 2025-02-12View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Reconciliation checks needing review

8 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2025-06-30

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2025-06-30

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2024-06-30

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2024-06-30

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2023-06-30

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2023-06-30

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2022-06-30

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2022-06-30

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.